Finland· FI-REL-REL45008
Lumark
A various diagnostic radiopharmaceuticals product containing lutetium (177lu) chloride, registered in Finland by IDB Holland B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) chloride is registered in 3 of 19 countries.
Countries holding a registration under ATC V09XX (various diagnostic radiopharmaceuticals), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Lutetium (177lu) chloride · ATC V09XX
3 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Lutetium (177Lu) chloride
- Manufacturer
- IDB Holland B.V.
- Country
- Finland (FI)
- ATC code
- V09XX
- ATC class
- Various diagnostic radiopharmaceuticals
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) chloride in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEndolucinBeta 40 GBq/ml Stamlösning till radioaktiva läkemedelITM Medical Isotopes GmbH
- IrelandEndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solutionITM Medical Isotopes GmbH
- GermanyLutencaCurium Romania Srl
- PolandIlumiraSHINE Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Lutenca
- Belgium · Monlutenca
- Germany · Lutenca
- Spain · Lutenca
- France · Lunca
- United Kingdom (Northern Ireland) · Monlutenca
- Iceland · Endolucinbeta, Ilumira
- Italy · Monlunca
- Liechtenstein · Endolucinbeta, Ilumira
- Netherlands · Monlutenca
- Norway · Endolucinbeta, Ilumira
- Portugal · Lutenca
- Sweden · Lutenca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ef0d620-7ce3-44d8-994e-2e12844b0dbe GET /v1/drugs/0ef0d620-7ce3-44d8-994e-2e12844b0dbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kantaliuos radioaktiivista lääkettä varten",
"route": "Antoreitti ei oleellinen",
"ddd_unit": null,
"strength": "80 GBq/ml",
"atc_label": "Muut diagnostiset radioaktiiviset lääkevalmisteet",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/15/1013/001",
"fimea_rel_id": "REL45008",
"authorised_at": "2015-06-19"
}See everything about lutetium (177lu) chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.